Drugs Online |
 |
 | ||
|
BONMAX Evista |
|
| ||
Drugs Online » Prescription Drugs 3 » BONMAX Evista Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.This medication is not recommended for use in women before menopause. It should not be used in children.This medication should not be used to prevent heart disease.How to use Raloxifene OralTake this medication by mouth usually once a day with or without food or as directed by your doctor. Use this medication regularly to get the most benefit from it. Remember to use it at the same time each day.Be sure to include adequate amounts of calcium and vitamin D in your diet. Consult your doctor or pharmacist to see if you need to take calcium/vitamin D supplements. Buy BONMAX Evista and other Prescription Drugs 3 products online at Medstore. 330
About BONMAX Evista: Product Type: Prescription Drugs 3 BONMAX ( Evista Generic Raloxifene ) BONMAX (Evista Generic Raloxifene) Evista Generic Raloxifene 60mg 28 (4 x 7) Evista Generic Raloxifene BONMAX
View more Prescription Drugs 3 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
